Fatty liver disease has become one of the fastest-growing health problems around the world. It happens when too much fat builds up inside the liver, an organ that plays a vital role in digestion, energy storage, and removing harmful substances from the body.
While a small amount of fat in the liver is normal, excessive fat can cause serious health problems over time.
Today, doctors refer to this condition as metabolic dysfunction-associated steatotic liver disease, or MASLD. The disease is closely linked to obesity, type 2 diabetes, high cholesterol, and other metabolic health problems. Experts estimate that around 40% of people worldwide may have MASLD, making it one of the most common liver disorders.
For some people, the disease becomes much more serious. Fatty liver can progress into a condition called metabolic dysfunction-associated steatohepatitis, or MASH. In addition to fat buildup, MASH causes inflammation and scarring in the liver.
Over time, the scarring can become severe and lead to cirrhosis, liver failure, or liver cancer. Because liver damage often develops silently over many years, many people do not realize they have the disease until significant harm has already occurred.
Despite the growing number of cases, treatment options remain limited. Currently, only one medication has received approval from the U.S. Food and Drug Administration (FDA) for treating MASH. This has created an urgent need for new and more effective therapies.
Now, researchers have uncovered promising new evidence that a naturally occurring hormone may help reverse some of the most serious effects of fatty liver disease.
The study, led by Dr. Matthew Potthoff at the University of Oklahoma and published in the journal Cell Metabolism, focused on a hormone called fibroblast growth factor 21, or FGF21. This hormone is produced naturally by the liver and plays an important role in regulating metabolism.
Scientists have been interested in FGF21 for several years because it appears to influence how the body uses fats and sugars. Several FGF21-based drugs are already being tested in advanced human clinical trials. However, researchers still wanted to better understand exactly how the hormone works.
In their study, the team found that FGF21 had remarkable effects in mice with fatty liver disease. The hormone not only reduced the amount of fat stored in the liver but also reversed fibrosis, the scarring process that causes some of the most dangerous complications of liver disease.
One of the most surprising findings was that these improvements occurred even while the mice continued eating a high-fat diet that would normally worsen liver damage. This suggests that FGF21 may be able to actively repair liver problems rather than simply prevent them.
The researchers discovered that FGF21 works through two major pathways. First, the hormone sends signals to the brain. The brain then changes nerve activity throughout the body in ways that help protect and improve liver function. Second, FGF21 sends direct signals to the liver itself, helping reduce cholesterol levels and improve metabolic health.
According to Dr. Potthoff, both pathways are important, but the communication between the liver and the brain appears to provide most of the benefits. He describes the process as a feedback system in which the liver informs the brain about the body’s metabolic state, and the brain responds by helping restore balance and protect the liver.
This brain-liver communication system is especially exciting because it resembles how another well-known group of medicines works. Drugs such as Ozempic contain compounds that mimic a hormone called GLP-1. These medicines have become widely known for helping people lose weight and manage type 2 diabetes.
Although GLP-1 and FGF21 are produced in different organs, they share an important feature. Both hormones act on the brain to influence metabolism throughout the body. Researchers believe this type of hormone-based signaling may be one of the most powerful ways to treat metabolic diseases.
The ability of FGF21 to reverse fibrosis is particularly significant. While reducing liver fat is important, fibrosis is often the most dangerous part of advanced fatty liver disease because it can permanently damage the liver’s structure and function. A treatment that can reverse fibrosis could dramatically improve outcomes for patients with MASH.
The researchers caution that these findings were observed in mice, and more studies are needed to determine whether the same benefits occur in humans. However, the results help explain why FGF21-based therapies have shown promise in clinical trials and provide valuable guidance for developing future treatments.
As research continues, FGF21 could become an important new tool in the fight against fatty liver disease. For millions of people living with MASLD and MASH, the discovery offers hope that safer and more effective treatments may soon become available.
By targeting the powerful connection between the liver and the brain, scientists may have found a new way to help the liver heal itself.
If you care about liver health, please read studies that refined fiber is link to liver cancer, and the best and worst foods for liver health.
For more health information, please see recent studies about how to boost your liver naturally, and simple ways to detox your liver.
Copyright © 2026 Knowridge Science Report. All rights reserved.
